TABLE II.

Baseline Characteristics - BMC vs Placebo

	BMC (n=30)	Placebo (n=10)	P Value
Age (years)	52.5 (43, 64)	57.5 (54, 59)	.193
Male / Female	25 / 5	6 / 4	.665
Diabetes	6	2	1.00
IABP	5	2	1.00
TIMI Flow = 0	26 / 30	8 / 10	1.00
Ischemic Time (hrs)	4.6 (2, 12)	2.9 (2.8, 10.6)	.508
Pre-Infarction Angina	10	2	.330
Postconditioning	3	3	.230
Peak Troponin (ng/ml)	7.7 (3.9, 10.8)	8.8 (5.6, 10.2)	.832
Peak CK (IU/ml)	2752 (1687, 4074)	2049 (852, 3987)	.446
Peak CKMB (IU/ml)	202 (149, 320)	291 (87, 368)	.804
Time from PCI to BMC infusion (Days)	4.5 (4,7)	5.5 (3, 7)	1.00
Number of BMCs injected	100 × 106	_____
CD34+ (%)	1.60 ± 0.73
CD34+/CD133+ (%)	0.77 ± 0.44
CD133+ (%)	0.16 ± 0.05

Data are expressed as the median with interquartile range

IABP – intra-aortic balloon pump